Clinical Trial to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Volunteers.

Clinical trial NCT05162274 · COMPLETED

Trial details

NCT number: NCT05162274
Sponsor: Yuhan Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Volunteers

Start date: 2021-11-30
Primary completion: 2022-01-14
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.